John Phillip, MD
Surgery · Johnston, RINPI 1285617696
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $41,202 of the $52,541 with a category attached, or 78.4%. Anika Therapeutics, Inc. accounts for 96.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $42,717 and has fallen 100.0% since, to $19 in 2025. Among surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $2765.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$51K
- Covidien LP$1K
- Musculoskeletal Transplant Foundation Inc.$114
- Smith+Nephew$104
- Encision Inc$31
- Innocoll Pharmaceuticals Limited$30
- plus $53 from 2 others
What the payments were for
- Consulting fees$1,4003%
- Food & beverage$4271%
- Ownership interest$41,20278%
- Other$9,51118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 4 | $50,713 |
| Covidien LP | 3 | $1,495 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $114 |
| Smith+Nephew | 5 | $104 |
| Encision Inc | 2 | $31 |
| Innocoll Pharmaceuticals Limited | 2 | $30 |
| Boston Scientific | 1 | $30 |
| Hikma Pharmaceuticals USA | 1 | $23 |
How this compares
$52,541 in reported general payments places this provider in the 95th percentile of 108 surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 12 | $4,173 |
| Omeprazole | 62 | $506 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $248 |
| Esomeprazole Magnesium | 14 | $221 |
| Ciprofloxacin Hcl | 15 | $153 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $113 |
Paid to pharmacies, not to this prescriber.
Other surgery in Johnston
- Jeannine GiovanniJohnston$17K
- Dieter PohlJohnston$8K
- Michael LinJohnston$3K
- Daniel ChristianJohnston$1K
- Michael RocchioJamestown$594K
- Joseph EspatProvidence$159K
- Marcoandrea GiorgiProvidence$63K
- Andrew LuhrsProvidence$51K
- Jordan HebertNewport$31K
- Taher GulamhuseinWarwick$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.